| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Beverly E Barton | |
| P2860 | cites work | Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex | Q24306425 |
| Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway | Q24531184 | ||
| Dendritic cells and the control of immunity | Q27860918 | ||
| Protein inhibitor of activated STAT3 regulates androgen receptor signaling in prostate carcinoma cells | Q28143456 | ||
| Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells | Q28204912 | ||
| SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130 | Q28211408 | ||
| Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components | Q28257845 | ||
| Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells | Q28592531 | ||
| Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6 | Q28637521 | ||
| Differential activation of acute phase response factor/Stat3 and Stat1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. II. Src homology SH2 domains define the specificity of stat factor activation | Q28637692 | ||
| IDO expression by dendritic cells: tolerance and tryptophan catabolism | Q29614752 | ||
| Tolerogenic dendritic cells | Q29618755 | ||
| IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. | Q33892268 | ||
| The Jak-STAT pathway | Q33899139 | ||
| Regulatory activity of autocrine IL-10 on dendritic cell functions | Q33938563 | ||
| Cytokine signaling in 2002: new surprises in the Jak/Stat pathway | Q34126053 | ||
| Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3. | Q34248349 | ||
| Dendritic cells giveth and taketh away | Q56903003 | ||
| Interleukin 6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis | Q68007067 | ||
| Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats | Q69840216 | ||
| A common nuclear signal transduction pathway activated by growth factor and cytokine receptors | Q70476706 | ||
| Pharmacogenomic analysis of rhIL-11 treatment in the HLA-B27 rat model of inflammatory bowel disease | Q73107327 | ||
| Subcutaneous or oral administration of rhIL-11 modulated the contact hypersensitivity response | Q73246658 | ||
| Matching SOCS with function | Q73451243 | ||
| WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection | Q74840049 | ||
| Specific ablation of Stat3beta distorts the pattern of Stat3-responsive gene expression and impairs recovery from endotoxic shock | Q77657683 | ||
| Beta 2-microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells | Q78806350 | ||
| The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity | Q80884527 | ||
| IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells | Q81476292 | ||
| The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis | Q81482647 | ||
| Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1) | Q81512203 | ||
| Signaling conformations of the tall cytokine receptor gp130 when in complex with IL-6 and IL-6 receptor | Q81749177 | ||
| Bow to your partner for signaling | Q81810921 | ||
| Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway | Q34314210 | ||
| Interleukin-6 and new strategies for the treatment of cancer, hyperproliferative diseases and paraneoplastic syndromes | Q34440657 | ||
| Spacing of palindromic half sites as a determinant of selective STAT (signal transducers and activators of transcription) DNA binding and transcriptional activity | Q34532143 | ||
| STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity | Q34762373 | ||
| The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses | Q35582560 | ||
| Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. | Q35835489 | ||
| The role of IL-27 in the development of T-cell responses during parasitic infections | Q35951809 | ||
| IL-6 transsignaling: the in vivo consequences | Q36116485 | ||
| Tuning of macrophage responses by Stat3-inducing cytokines: molecular mechanisms and consequences in infection | Q36257846 | ||
| A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis | Q36371158 | ||
| A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice | Q36376640 | ||
| Reflections on STAT3, STAT5, and STAT6 as fat STATs | Q37508544 | ||
| Cutting edge: CpG oligonucleotides induce splenic CD19+ dendritic cells to acquire potent indoleamine 2,3-dioxygenase-dependent T cell regulatory functions via IFN Type 1 signaling | Q38319700 | ||
| SOCS3 regulates the plasticity of gp130 signaling | Q38354507 | ||
| Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice | Q39750347 | ||
| IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses | Q39797207 | ||
| Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity | Q40351340 | ||
| Activation of dendritic cells via inhibition of Jak2/STAT3 signaling | Q40370364 | ||
| Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27. | Q40395233 | ||
| Determinants governing the potency of STAT3 activation via the individual STAT3-recruiting motifs of gp130. | Q40415081 | ||
| PIASy-deficient mice display modest defects in IFN and Wnt signaling | Q40495312 | ||
| Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. | Q40605195 | ||
| Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division | Q40686234 | ||
| STAT3 is required for the gp130-mediated full activation of the c-myc gene | Q42753357 | ||
| Absence of endogenous interleukin-6 enhances the inflammatory response during acute pancreatitis induced by cerulein in mice | Q44088495 | ||
| Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase | Q44135171 | ||
| T cell apoptosis by tryptophan catabolism | Q44137068 | ||
| Protective effect of anti-interleukin (IL)-6 antibody against endotoxin, associated with paradoxically increased IL-6 levels | Q44301484 | ||
| A critical role for Stat3 signaling in immune tolerance | Q44589709 | ||
| Oral Treatment with Recombinant Human Interleukin-11 Improves Mucosal Transport in the Colon of Human Leukocyte Antigen-B27 Transgenic Rats | Q44625339 | ||
| Modulation of tryptophan catabolism by regulatory T cells. | Q44632333 | ||
| WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production | Q44721986 | ||
| T cell apoptosis by kynurenines. | Q44943853 | ||
| Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats | Q45098707 | ||
| Interleukin-6 administration has no acute hemodynamic or hematologic effect in the dog. | Q45110145 | ||
| Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. | Q46499878 | ||
| A minor population of splenic dendritic cells expressing CD19 mediates IDO-dependent T cell suppression via type I IFN signaling following B7 ligation | Q46557704 | ||
| Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis | Q47685842 | ||
| Leukemia inhibitory factor is linked to regulatory transplantation tolerance. | Q50774069 | ||
| STAT3 regulates NF-kappaB recruitment to the IL-12p40 promoter in dendritic cells. | Q50799062 | ||
| Are dendritic cells afraid of commitment? | Q50986652 | ||
| STAT3 is required for Flt3L-dependent dendritic cell differentiation. | Q51012505 | ||
| The transcriptional repressor Gfi1 controls STAT3-dependent dendritic cell development and function. | Q52046758 | ||
| IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. | Q53634876 | ||
| WSX-1 over-expression in CD4(+) T cells leads to hyperproliferation and cytokine hyperproduction in response to TCR stimulation. | Q53674763 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| P304 | page(s) | 459-470 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | Expert Opinion on Therapeutic Targets | Q5421214 |
| P1476 | title | STAT3: a potential therapeutic target in dendritic cells for the induction of transplant tolerance | |
| P478 | volume | 10 |
| Q47865606 | Balancing inflammation and tolerance in vivo through dendritic cells by the commensal Candida albicans |
| Q33581824 | Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells |
| Q47884713 | Cutting edge: Negative regulation of dendritic cells through acetylation of the nonhistone protein STAT-3. |
| Q37417083 | Expression and function of immunoglobulin-like transcripts on tolerogenic dendritic cells |
| Q50871361 | Extracellular Hsp70 inhibits pro-inflammatory cytokine production by IL-10 driven down-regulation of C/EBPβ and C/EBPδ. |
| Q33336590 | Generation of a novel regulatory NK cell subset from peripheral blood CD34+ progenitors promoted by membrane-bound IL-15 |
| Q50034338 | Genome-Wide STAT3 Binding Analysis after Histone Deacetylase Inhibition Reveals Novel Target Genes in Dendritic Cells. |
| Q35016985 | HDAC inhibition and graft versus host disease |
| Q57821146 | Interferon-α Up-Regulates the Expression of PD-L1 Molecules on Immune Cells Through STAT3 and p38 Signaling |
| Q43239054 | Intranasally delivered siRNA targeting PI3K/Akt/mTOR inflammatory pathways protects from aspergillosis. |
| Q44603812 | Latency-associated protein Acr1 impairs dendritic cell maturation and functionality: a possible mechanism of immune evasion by Mycobacterium tuberculosis |
| Q24321398 | Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway |
| Q54617418 | PD-L1 expression on tolerogenic APCs is controlled by STAT-3. |
| Q38265472 | STAT3 as a possible therapeutic target in human malignancies: lessons from acute myeloid leukemia |
| Q90540850 | Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution |
| Q33715925 | Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells |
| Q42146676 | The anti-inflammatory mechanisms of Hsp70 |
Search more.